相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
Adriana Estrada-Bernal et al.
CLINICAL CANCER RESEARCH (2021)
Klotho deficiency intensifies hypoxia-induced expression of IFN-α/β through upregulation of RIG-I in kidneys
Asako Urabe et al.
PLOS ONE (2021)
Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy
Zhe Fu et al.
CELLS (2021)
Therapeutic targeting of the hypoxic tumour microenvironment
Dean C. Singleton et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
HIF-1α is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes
Travis Peng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The cGAS-STING pathway as a therapeutic target in inflammatory diseases
Alexiane Decout et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Lawrence Fong et al.
CANCER DISCOVERY (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights
Sachin Puri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Interferon-Independent Activities of Mammalian STING Mediate Antiviral Response and Tumor Immune Evasion
Jianjun Wu et al.
IMMUNITY (2020)
Interferon-independent STING signaling promotes resistance to HSV-1 in vivo
Livia H. Yamashiro et al.
NATURE COMMUNICATIONS (2020)
The degree of conserved interferon gamma signaling guides response to immune checkpoint blockade therapy
Catherine Grasso et al.
CANCER RESEARCH (2020)
Hypoxia Induces Transcriptional and Translational Downregulation of the Type I IFN Pathway in Multiple Cancer Cell Types
Ana Miar et al.
CANCER RESEARCH (2020)
Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS
Weina Zhang et al.
CELL (2019)
Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2019)
Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity
Scott R. Walsh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
A Multifunctional Biomimetic Nanoplatform for Relieving Hypoxia to Enhance Chemotherapy and Inhibit the PD-1/PD-L1 Axis
Mei-Zhen Zou et al.
SMALL (2018)
Preliminary phase 1 profile of BMS-986179, an anti-CD73 antibody, in combination with nivolumab in patients with advanced solid tumors
Lillian L. Siu et al.
CANCER RESEARCH (2018)
Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Phase I/II study of the A2AR antagonist NIR178 (PBF-509), an oral immunotherapy, in patients (pts) with advanced NSCLC.
Alberto Chiappori et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles
Zaigang Zhou et al.
THERANOSTICS (2018)
Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance
Megha Budhwani et al.
FRONTIERS IN ONCOLOGY (2018)
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
Assaf Marcus et al.
IMMUNITY (2018)
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma
Stephen M. F. Jamieson et al.
JCI INSIGHT (2018)
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Nicole E. Scharping et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
Paul A. Beavis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS
Min-Zu Wu et al.
NATURE CELL BIOLOGY (2017)
cGAS is essential for the antitumor effect of immune checkpoint blockade
Hua Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion
Priya Luthra et al.
MBIO (2017)
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
Scott Gettinger et al.
CANCER DISCOVERY (2017)
RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation
Christina Engel et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis
Noemi De Luna et al.
SCIENTIFIC REPORTS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
Henrique Lemos et al.
CANCER RESEARCH (2016)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses
Katarzyna Blaszczyk et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer
Qing Chen et al.
NATURE (2016)
Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization
Kheng Newick et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho et al.
CELL (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling
Stephan Wilmes et al.
JOURNAL OF CELL BIOLOGY (2015)
Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9
Yao Liu et al.
JOURNAL OF HEPATOLOGY (2015)
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
Huimin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
Siqi Liu et al.
SCIENCE (2015)
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M. Hatfield et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Interferon-Stimulated Genes: A Complex Web of Host Defenses
William M. Schneider et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8+ T cells
Joanne Y. H. Lim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
Damya Laoui et al.
CANCER RESEARCH (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Cytosolic-DNA-Mediated, STING-Dependent Proinflammatory Gene Induction Necessitates Canonical NF-κB Activation through TBK1
Takayuki Abe et al.
JOURNAL OF VIROLOGY (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Inflammation-driven carcinogenesis is mediated through STING
Jeonghyun Ahn et al.
NATURE COMMUNICATIONS (2014)
Extracellular adenosine-mediated modulation of regulatory T cells
Akio Ohta et al.
FRONTIERS IN IMMUNOLOGY (2014)
Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
Bertrand Allard et al.
CLINICAL CANCER RESEARCH (2013)
Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
Zaheed Husain et al.
JOURNAL OF IMMUNOLOGY (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
Jiaxi Wu et al.
SCIENCE (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
Type I Interferon Suppresses Type II Interferon-Triggered Human Anti-Mycobacterial Responses
Rosane M. B. Teles et al.
SCIENCE (2013)
Recognition of lipopolysaccharide pattern by TLR4 complexes
Beom Seok Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
A Virological View of Innate Immune Recognition
Akiko Iwasaki
ANNUAL REVIEW OF MICROBIOLOGY, VOL 66 (2012)
Interferon signatures in immune disorders and disease
Samuel Forster
IMMUNOLOGY AND CELL BIOLOGY (2012)
Oxygen Gas-Filled Microparticles Provide Intravenous Oxygen Delivery
John N. Kheir et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Nucleic Acid Recognition by the Innate Immune System
Roman Barbalat et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
Byron C. Burnette et al.
CANCER RESEARCH (2011)
Lactate: A Metabolic Key Player in Cancer
Franziska Hirschhaeuser et al.
CANCER RESEARCH (2011)
Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-alpha
Shintaro Tomita et al.
CANCER SCIENCE (2011)
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Jonathan W. Wojtkowiak et al.
MOLECULAR PHARMACEUTICS (2011)
The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells
Zhiqiang Zhang et al.
NATURE IMMUNOLOGY (2011)
Epigenetic Silencing of IRF7 and/or IRF5 in Lung Cancer Cells Leads to Increased Sensitivity to Oncolytic Viruses
Qunfang Li et al.
PLOS ONE (2011)
Interferon-stimulated genes and their antiviral effector functions
John W. Schoggins et al.
CURRENT OPINION IN VIROLOGY (2011)
T-Cell Activation under Hypoxic Conditions Enhances IFN-gamma Secretion
Jessica Roman et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression
Andrew L. Doedens et al.
CANCER RESEARCH (2010)
Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death
Kai-xin Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
Johanna Chiche et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A. Corzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Positive Regulation of Interferon Regulatory Factor 3 Activation by Herc5 via ISG15 Modification
He-Xin Shi et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Matthew P. R. Berry et al.
NATURE (2010)
IFI16 is an innate immune sensor for intracellular DNA
Leonie Unterholzner et al.
NATURE IMMUNOLOGY (2010)
Overview of the biology of type I interferons
George D. Kalliolias et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Interferon-Gamma Induces Prolyl Hydroxylase (PHD)3 Through a STAT1-Dependent Mechanism in Human Endothelial Cells
Scott A. Gerber et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Role of Hypoxia in the Hallmarks of Human Cancer
Kai Ruan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Hiroki Ishikawa et al.
NATURE (2009)
ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response
Ying Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
Marco Prinz et al.
IMMUNITY (2008)
The Stability of the Ternary Interferon-Receptor Complex Rather than the Affinity to the Individual Subunits Dictates Differential Biological Activities
Eyal Kalie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
NKG2D ligands:: key targets of the immune response
Segundo Gonzalez et al.
TRENDS IN IMMUNOLOGY (2008)
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response
Akinori Takaoka et al.
NATURE (2007)
SOCS1 silencing enhances antitumor activity of type IIFNs by regulating apoptosis in neuroendocrine tumor cells
Kathrin Zitzmann et al.
CANCER RESEARCH (2007)
Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes
C. Feder-Mengus et al.
BRITISH JOURNAL OF CANCER (2007)
Importance of culturing primary lymphocytes at physiological oxygen levels
Kondala R. Atkuri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine
James J. Kobie et al.
JOURNAL OF IMMUNOLOGY (2006)
Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: Role of HIF in antiviral response
Irene I. L. Hwang et al.
JOURNAL OF VIROLOGY (2006)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus
Yanick J. Crow et al.
NATURE GENETICS (2006)
The DNA damage response arouses the immune system
S Gasser et al.
CANCER RESEARCH (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity
JE Fenner et al.
NATURE IMMUNOLOGY (2006)
Type I inteferon gene induction by the interferon regulatory factor family of transcription factors
Kenya Honda et al.
IMMUNITY (2006)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The role of ICPO-null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma
JL Hummel et al.
MOLECULAR THERAPY (2005)
Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation
Y Okabe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
T Kawai et al.
NATURE IMMUNOLOGY (2005)
Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity
M Yoneyama et al.
JOURNAL OF IMMUNOLOGY (2005)
A critical function for type I interferons in cancer immunoediting
GP Dunn et al.
NATURE IMMUNOLOGY (2005)
SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling
T Tanaka et al.
IMMUNITY (2005)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression
GP Dunn et al.
CANCER RESEARCH (2005)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9
A Krug et al.
BLOOD (2004)
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
M Yoneyama et al.
NATURE IMMUNOLOGY (2004)
Interferons, interferon-like cytokines, and their receptors
S Pestka et al.
IMMUNOLOGICAL REVIEWS (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection
H Hemmi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor
KGS Kumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Triggering the interferon antiviral response through an IKK-related pathway
S Sharma et al.
SCIENCE (2003)
IKKε and TBK1 are essential components of the IRF3 signaling pathway
KA Fitzgerald et al.
NATURE IMMUNOLOGY (2003)
Multiple mutations and cancer
LA Loeb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Suppression of lymphoma and epithelial malignancies effected by interferon γ
SEA Street et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor
D Lando et al.
GENES & DEVELOPMENT (2002)
FIH-1:: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
PC Mahon et al.
GENES & DEVELOPMENT (2001)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
M Ohh et al.
NATURE CELL BIOLOGY (2000)
Differential tumor surveillance by natural killer (NK) and NKT cells
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
